Submissions of abstracts, symposia, post-graduate courses, and workshops are now closed.
Late-breaker abstract submissions will open from 10 July to 5 August.
Satellite session submissions are open until 12 July with a second round of submissions from 13 July – 13 September, upon availability.
Your session must be submitted under one of the official tracks for the conference:
| Track A: Basic and translational research |
|---|
| A1. Immunology |
| A2. Drug and vaccine development |
| A3. TB diagnostics, including drug-resistance determination |
| Track B: Clinical and operational research |
|---|
| B1. TB diagnostics |
| B2. Clinical trials and operational research for new treatments for DS-TB and MDR-TB in adults |
| B3. Clinical trials and operational research for COPD, pneumonia, asthma and other lung health in adults |
| B4. Clinical trials and operational research for new treatments for DS-TB and MDR-TB in children |
| B5. Clinical trials and operational research for COPD, pneumonia, asthma and other lung health in children |
| B6. TB and co-infections: including HIV and diabetes |
| B7. Lung health other than TB, and co-infections |
| B8. Tobacco and co-morbidities: including NCDs, TB and HIV |
| Track C: Policies and clinical & programmatic implementation |
|---|
| C1. TB infection (LTBI) |
| C2. TB care and treatment in DS-TB |
| C3. TB care and treatment in DR-TB |
| C4. Paediatric TB treatment and care |
| C5. Paediatric lung disease, excluding TB |
| C6. Maternal and Child Health |
| C7. Patient-centred care |
| C8. Access to Quality TB Care and Services |
| C9. Global and Local Policies and Politics, including funding |
| C10. TB laboratory service implementation and operations |
| C11. TB education and training |
| C12. Tobacco control and Tobacco industry interference |
| C13. MPOWER for tobacco control |
| Track D: Epidemiology |
|---|
| D1. TB epidemiology in adults |
| D2. TB epidemiology in children |
| D3. Epidemiology of COPD, pneumonia, asthma and other lung health conditions in adults |
| D4. Epidemiology of COPD, pneumonia, asthma and other lung health conditions in children |
| D5. Epidemiology of transmission and Latent TB infection (LTBI) |
| D6. TB infection control |
| D7. HIV-TB and other HIV-related lung health |
| D8. Modelling |
| D9. Health Economics |
| D10. Tobacco-related epidemiology |
| D11. E-cigarettes and non-combustible tobacco products |
| Track E: Politics, civil society and human rights |
|---|
| E1. Civil society, advocacy and community engagement |
| E2. Key affected populations: behavioural, social, and cultural issues and contexts |
| E3. Human rights |
| E4. Ethics |
| E5. Communication/Social media |
| Track F: Zoonotic TB |
|---|
| F1. Basic science and zoonotic diagnostics |
| F2. Zoonotic Treatment |
| F3. Zoonotic Epidemiology |
| F4. One Health |